Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank86
3Y CAGR+7.5%
5Y CAGR+15.5%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+7.5%/yr
vs +13.5%/yr prior
5Y CAGR
+15.5%/yr
Recent deceleration
Acceleration
-5.9pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $46.16M | -6.9% |
| 2024 | $49.60M | -1.1% |
| 2023 | $50.15M | +35.1% |
| 2022 | $37.12M | +14.3% |
| 2021 | $32.47M | +44.8% |
| 2020 | $22.43M | +18.8% |
| 2019 | $18.87M | -15.8% |
| 2018 | $22.40M | +29.9% |
| 2017 | $17.24M | +219.4% |
| 2016 | $5.40M | - |